These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33437495)

  • 1. Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research.
    Bonney EY; Lamptey H; Aboagye JO; Zaab-Yen Abana C; Boateng AT; Quansah DNK; Obo-Akwa A; Ganu VJ; Puplampu P; Kyei GB;
    J Virus Erad; 2021 Mar; 7(1):100027. PubMed ID: 33437495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding participant perspectives around HIV-1 cure-related studies involving antiretroviral analytical treatment interruptions in the United Kingdom.
    Lee MJ; Godakandaarachchi P; Collins S; Racz M; Sharp A; Fidler S; Fox J
    J Virus Erad; 2023 Dec; 9(4):100360. PubMed ID: 38188642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare Provider Perspectives on HIV Cure Research in Ghana.
    Lamptey H; Newcomb B; Bonney EY; Aboagye JO; Puplampu P; Ganu VJ; Ansa G; Oliver-Commey J; Kyei GB
    AIDS Res Treat; 2023; 2023():8158439. PubMed ID: 37292229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infection.
    van Paassen P; Dijkstra M; Peay HL; Rokx C; Verbon A; Reiss P; Prins JM; Henderson GE; Rennie S; Nieuwkerk PT; de Bree GJ
    J Virus Erad; 2022 Jun; 8(2):100072. PubMed ID: 35769632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US.
    Dubé K; Evans D; Sylla L; Taylor J; Weiner BJ; Skinner A; Thirumurthy H; Tucker JD; Rennie S; Greene SB
    J Virus Erad; 2017 Jan; 3(1):40-50.e21. PubMed ID: 28275457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions of HIV Virologic Control Strategies Among Younger and Older Age Groups of People Living with HIV in the United States: A Cross-Sectional Survey.
    Saberi P; Eskaf S; Sauceda J; Evans D; Dubé K
    AIDS Res Hum Retroviruses; 2020 Jul; 36(7):606-615. PubMed ID: 32368934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of subclinical carotid atherosclerosis and vascular risk factors among people living with HIV in Ghana.
    Sarfo FS; Nichols M; Agyei B; Singh A; Ennin E; Nyantakyi AD; Asibey SO; Tagge R; Gebregziabher M; Jenkins C; Ovbiagele B
    J Neurol Sci; 2019 Feb; 397():103-111. PubMed ID: 30599299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy.
    Dubé K; Eskaf S; Evans D; Sauceda J; Saberi P; Brown B; Averitt D; Martel K; Meija M; Campbell D; Barr L; Kanazawa J; Perry K; Patel H; Luter S; Poteat T; Auerbach JD; Wohl DA
    AIDS Res Hum Retroviruses; 2020 Apr; 36(4):324-348. PubMed ID: 31608651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC).
    Protière C; Spire B; Mora M; Poizot-Martin I; Préau M; Doumergue M; Morlat P; Zucman D; Goujard C; Raffi F; Lambotte O; Suzan-Monti M
    PLoS One; 2017; 12(11):e0187489. PubMed ID: 29095883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A global survey of HIV-positive people's attitudes towards cure research.
    Simmons R; Kall M; Collins S; Cairns G; Taylor S; Nelson M; Fidler S; Porter K; Fox J;
    HIV Med; 2017 Feb; 18(2):73-79. PubMed ID: 27167600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Cure Research: Risks Patients Expressed Willingness to Accept.
    Kratka A; Ubel PA; Scherr K; Murray B; Eyal N; Kirby C; Katz MN; Holtzman L; Pollak K; Freedburg K; Blumenthal-Barby J
    Ethics Hum Res; 2019 Nov; 41(6):23-34. PubMed ID: 31743627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation in HIV cure-related research: a scoping review of the proxy literature and implications for future research.
    Dubé K; Ramirez C; Handibode J; Taylor J; Skinner A; Greene S; Tucker JD
    J Virus Erad; 2015 Oct; 1(4):250-256. PubMed ID: 26866059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bringing social context into global biomedical HIV cure-related research: An urgent call to action.
    Miall A; McLellan R; Dong K; Ndung'u T; Saberi P; Sauceda JA; Dubé K
    J Virus Erad; 2022 Mar; 8(1):100062. PubMed ID: 35169489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options.
    Dubé K; Campbell DM; Perry KE; Kanazawa JT; Saberi P; Sauceda JA; Poteat T; Evans D
    AIDS Res Hum Retroviruses; 2020 Dec; 36(12):1054-1058. PubMed ID: 32829645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment and ethical considerations in HIV cure trials requiring treatment interruption.
    Arnold MP; Evans D; Vergel N
    J Virus Erad; 2015 Jan; 1(1):43-8. PubMed ID: 27482394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to Engage Young People in HIV Cure Research.
    Saberi P; Campbell CK; Venegas M; Dubé K
    AIDS Res Hum Retroviruses; 2022 Jan; 38(1):2-4. PubMed ID: 33677996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.
    Maina EK; Adan AA; Mureithi H; Muriuki J; Lwembe RM
    Curr HIV Res; 2021; 19(1):14-26. PubMed ID: 32819259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies.
    Lau JSY; Smith MZ; Allan B; Martinez C; Power J; Lewin SR; McMahon JH
    AIDS Res Ther; 2020 Nov; 17(1):65. PubMed ID: 33168019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment.
    Henderson GE; Peay HL; Kroon E; Cadigan RJ; Meagher K; Jupimai T; Gilbertson A; Fisher J; Ormsby NQ; Chomchey N; Phanuphak N; Ananworanich J; Rennie S
    J Med Ethics; 2018 Apr; 44(4):270-276. PubMed ID: 29127137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.